Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)
97.00
+2.00 (2.11%)
Apr 17, 2026, 3:30 PM JST
TYO:4596 Revenue
In the year 2025, Kubota Pharmaceutical Holdings had annual revenue of 21.00M JPY, down -22.22%. Kubota Pharmaceutical Holdings had revenue of 2.77M in the quarter ending December 31, 2025, a decrease of -71.90%.
Revenue
21.00M
Revenue Growth
-22.22%
P/S Ratio
533.06
Revenue / Employee
2.63M
Employees
8
Market Cap
11.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21.00M | -6.00M | -22.22% |
| Dec 31, 2024 | 27.00M | -12.00M | -30.77% |
| Dec 31, 2023 | 39.00M | 31.00M | 387.50% |
| Dec 31, 2022 | 8.00M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kidswell Bio | 7.06B |
| StemCell Institute | 2.78B |
| Immuno-Biological Laboratories | 1.03B |
| MEDINET | 998.00M |
| OncoTherapy Science | 784.00M |
| Carna Biosciences | 579.00M |
| CellSeed | 161.00M |
| Nano Holdings | 155.00M |